» Articles » PMID: 9008718

Genotoxicity of the Laxative Drug Components Emodin, Aloe-emodin and Danthron in Mammalian Cells: Topoisomerase II Mediated?

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 1996 Dec 20
PMID 9008718
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

1,8-Dihydroxyanthraquinones are under debate as plant-derived carcinogens that are found in laxatives, food colors, and possibly vegetables. Published genotoxicity data are controversial, and so three of them (emodin, danthron and aloe-emodin) were tested in a number of in vitro assay systems. All three compounds induced tk-mutations in mouse lymphoma L5178Y cells. Induction of micronuclei also occurred in the same cell line, and was dose-dependent, with the potency ranking being danthron > aloe-emodin > emodin. In a DNA decatenation assay with a network of mitochondrial DNA of C. fasciulata, all three test compounds inhibited the topoisomerase II-mediated decatenation. Danthron and aloe-emodin, but not emodin, increased the fraction of DNA moving into comet tails when tested at concentrations around 50 microM in single-cell gel-electrophoresis assays (SCGE; comet assay). Comet assays were also used in modified form to determine whether pretreatment of the cells with the test compounds would reduce the effects of etoposide, a potent topoisomerase II inhibitor. All three test chemicals were effective in this pretreatment protocol, with danthron again being the most potent. Given clearcut evidence of their genotoxic activity, further research on the human cancer risk of these compounds may be warranted.

Citing Articles

Genotoxicity testing of the anthraquinone dye Alizarin Red S.

Bauer B, Rossi H, Hintzsche H Curr Res Toxicol. 2025; 8():100208.

PMID: 39811826 PMC: 11731281. DOI: 10.1016/j.crtox.2024.100208.


In Vitro Toxicity Assessment of Anthraquinone Aglycone Extract.

Yli-Oyra J, Herrala M, Kovakoski H, Huuskonen E, Toukola P, Raisanen R J Fungi (Basel). 2024; 10(6).

PMID: 38921356 PMC: 11204901. DOI: 10.3390/jof10060369.


Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.

Qiu C, Zhang J, Wu B, Xu C, Pang H, Tu Q J Nanobiotechnology. 2023; 21(1):456.

PMID: 38017573 PMC: 10685519. DOI: 10.1186/s12951-023-02165-x.


Complementary medicines used in ulcerative colitis and unintended interactions with cytochrome P450-dependent drug-metabolizing enzymes.

Sen A Turk J Med Sci. 2022; 52(5):1425-1447.

PMID: 36422483 PMC: 10395683. DOI: 10.55730/1300-0144.5482.


Development of an LC-DAD-MS-Based Method for the Analysis of Hydroxyanthracene Derivatives in Food Supplements and Plant Materials.

Loschi F, Faggian M, Sut S, Ferrarese I, Maccari E, Peron G Molecules. 2022; 27(6).

PMID: 35335294 PMC: 8955537. DOI: 10.3390/molecules27061932.